Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on September 11th, 2023%
Results of a clinical trial show one radiologist using software with artificial intelligence can detect more breast cancer cases in mammograms than current reviews by two radiologists. . . . → Read More: A.I. Mammogram Screening Shown to Improve Cancer Detection
By Alan, on August 19th, 2023%
As the climate crisis focuses more attention on alternatives to fossil fuels, nuclear energy is gaining more popular support in the U.S. as one of those alternatives. . . . → Read More: Infographic – Nuclear Power Support Grows in U.S.
By Alan, on July 28th, 2023%
The U.S. Food and Drug Administration issued new regulatory guidance for clinical trials of medical devices designed to prevent or treat opioid use disorder. . . . → Read More: FDA Issues Guidance for Opioid Therapy Device Trials
By Alan, on July 25th, 2023%
A biotechnology company creating living tissue from a person’s stem cells says it received FDA clearance for a clinical trial of its replacement knee cartilage. . . . → Read More: Trial Cleared for Lab-Grown Replacement Knee Cartilage
By Alan, on July 22nd, 2023%
A recent survey shows majorities of American adults would like technology companies or the government to restrict the spread of false information online. . . . → Read More: Infographic – Most in U.S. Favor False Online Info Limits
By Alan, on July 20th, 2023%
A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status
By Alan, on June 24th, 2023%
A recent survey shows a solid bipartisan majority of U.S. adults favors at least some government regulation of artificial intelligence, including people who say they use A.I. . . . → Read More: Infographic – U.S. Public Backs A.I. Regulation
By Alan, on June 16th, 2023%
A review of insurance claims shows patients facing obstacles to coverage for their migraine therapies are also more likely to need emergency care for treatment. . . . → Read More: Insurance Barriers, Migraine Hospital Visits Linked
By Alan, on April 26th, 2023%
A study of insurance claims records matching the design of randomized clinical trials shows claims data can in some cases resemble clinical trial results to make causal inferences. . . . → Read More: Real World Evidence Shown to Emulate Some Clinical Trials
By Alan, on April 10th, 2023%
A biotechnology industry group calls Friday’s ruling in a Federal district court to suspend approval of the drug mifepristone “an assault on science.” . . . → Read More: Biotech Group Blasts Reproductive Drug Ruling
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|